CoChat

IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62

Open access
Ball, Dimity H., Al-Riyami, Lamyaa, Harnett, William, Harnett, Margaret M. · 2018 · Scientific Reports

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

ES-62 is a secreted parasitic worm-derived immunomodulator that exhibits therapeutic potential in allergy by downregulating aberrant MyD88 signalling to normalise the inflammatory phenotype and mast cell responses. IL-33 plays an important role in driving mast cell responses and promoting type-2 allergic inflammation, particularly with respect to asthma, via MyD88-integrated crosstalk amongst the IL-33 receptor (ST2), TLR4 and FcεRI. We have now investigated whether ES-62 targets this pathogenic network by subverting ST2-signalling, specifically by characterising how the functional outcomes of crosstalk amongst ST2, TLR4 and FcεRI are modulated by the worm product in wild type and ST2-deficient mast cells. This analysis showed that whilst ES-62 inhibits IL-33/ST2 signalling, the precise functional modulation observed varies with receptor usage and/or mast cell phenotype. Thus, whilst ES-62’s harnessing of the capacity of ST2 to sequester MyD88 appears sufficient to mediate its inhibitory effects in peritoneal-derived serosal mast cells, downregulation of MyD88 expression appears to be required to dampen the higher levels of cytokine production typically released by bone marrow-derived mucosal mast cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-22716-9

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 IL-33 stimulated cytokine production is ST2-dependent and enhanced by IgE-mediated sensitisation of PDMCs and BMMCs. PDMCs (a–f) and BMMCs (g,h) derived from WT or ST2−/− (BALB/c) mice were sensitized (a–h) or not (a–d) with murine anti-DNP IgE (0.5 μg/ml) overnight then stimulated with IL-33 (100 ng/ml, (a–c); 10 ng/ml, e-h) for 24 h at 37 °C before release of IL-6, IL-13 or CCL2 was measured by ELISA. Data are presented as the mean values of triplicate samples ± SD and are from single experiments representative of 2 (a–c) and 3 (e–h) independent experiments. Statistical analysis was performed using One-way ANOVA with Bonferroni’s multiple comparison test where *p < 0.05 and **p < 0.01. Flow cytometric analysis (d) of PDMCs sensitized (black line), or not (red line), with murine anti-DNP IgE overnight were gated for live 7AAD- cells and then analysed for ST2 expression against the relevant isotype control obtained with non-sensitised cells (grey plot).
Figure 1 IL-33 stimulated cytokine production is ST2-dependent and enhanced by IgE-mediated sensitisation of PDMCs and BMMCs. PDMCs (a–f) and BMMCs (g,h) derived from WT or ST2−/− (BALB/c) mice were sensitized (a–h) or not (a–d) with murine anti-DNP IgE (0.5 μg/ml) overnight then stimulated with IL-33 (100 ng/ml, (a–c); 10 ng/ml, e-h) for 24 h at 37 °C before release of IL-6, IL-13 or CCL2 was measured by ELISA. Data are presented as the mean values of triplicate samples ± SD and are from single experiments representative of 2 (a–c) and 3 (e–h) independent experiments. Statistical analysis was performed using One-way ANOVA with Bonferroni’s multiple comparison test where *p < 0.05 and **p < 0.01. Flow cytometric analysis (d) of PDMCs sensitized (black line), or not (red line), with murine anti-DNP IgE overnight were gated for live 7AAD- cells and then analysed for ST2 expression against the relevant isotype control obtained with non-sensitised cells (grey plot).CC BY · PubMed Central
Figure 2 IL-33-stimulated ERK and NF-κB signalling is ST2-dependent and enhanced by IgE-mediated sensitisation of PDMCs and BMMCs. (a) PDMCs sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight (IgE) or not (PBS) were cultured with IL-33 (10 ng/ml) for the indicated times and expression of activated (dually phosphorylated) and total ERK1 (p44) and ERK2 (p42) MAPK and IκBα analysed by Western blotting. β-actin was used as a loading control. (b) Wild type (WT) and ST2 −/− BMMCs sensitised with IgE were stimulated with IL-33 (10 ng/ml) for the indicated times and expression of activated (dually phosphorylated) and total ERK1 (p44) and ERK2 (p42) MAPK and IκBα analysed by Western blotting. β-actin was used as a loading control.
Figure 2 IL-33-stimulated ERK and NF-κB signalling is ST2-dependent and enhanced by IgE-mediated sensitisation of PDMCs and BMMCs. (a) PDMCs sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight (IgE) or not (PBS) were cultured with IL-33 (10 ng/ml) for the indicated times and expression of activated (dually phosphorylated) and total ERK1 (p44) and ERK2 (p42) MAPK and IκBα analysed by Western blotting. β-actin was used as a loading control. (b) Wild type (WT) and ST2 −/− BMMCs sensitised with IgE were stimulated with IL-33 (10 ng/ml) for the indicated times and expression of activated (dually phosphorylated) and total ERK1 (p44) and ERK2 (p42) MAPK and IκBα analysed by Western blotting. β-actin was used as a loading control.CC BY · PubMed Central
Figure 3 The failure of IL-33 to induce mast cell degranulation is associated with lack of intracellular mobilisation of calcium. PDMCs (a,c) and BMMCs (b,d) were sensitized with murine anti-DNP IgE (0.5 μg/ml) or not (a,b) and then stimulated with DNP-HSA (0.5 µg/ml) to induce cross-linking of FcεRI (XL), IL-33 (10 ng/ml) or PMA plus Ionomycin (both 1 μM) for 30 mins at 37 °C. Degranulation was determined as the % β-hexosaminidase released relative to the total activity of the cells and data are presented from a single experiment (a,b) or mean ± SEM values from the combined results of five (c) or three (d; IL-33, n = 2) independent experiments where statistical analysis was by one-way ANOVA with Bonferroni’s post test and *p < 0.05, **p < 0.01 and ***p < 0.001. WT or ST2 −/− PDMCs (e–g) and BMMCs (h,i) loaded with Fura-2/AM and sensitised or not (e) with murine anti-DNP IgE (0.5 μg/ml) were stimulated at 50 s in serum-free HBSS with 100 ng/ml IL-33. Calcium mobilisation was recorded in real-time and for the analysis of intracellular mobilisation alone, the cells were stimulated in calcium-free buffer supplemented with 100 µM EGTA to remove all extracellular calcium (−Ca2+; g, i). Data are presented as the mean (baseline subtracted) values ± SEM from replicate biological analyses collated from at least two independent experiments as follows: for PDMCs, e: IL-33, n = 3, IL-33 + IgE, n = 4; f: WT n = 6, ST2−/− n = 5; g: IL-33 n = 7, IL-33-Ca2+ n = 7; for BMMCs, h: WT n = 6, ST2−/− n = 5; i: IL-33 n = 10, IL-33-Ca2+ n = 9. Statistical analysis was by two-way ANOVA where ***p < 0.001.
Figure 3 The failure of IL-33 to induce mast cell degranulation is associated with lack of intracellular mobilisation of calcium. PDMCs (a,c) and BMMCs (b,d) were sensitized with murine anti-DNP IgE (0.5 μg/ml) or not (a,b) and then stimulated with DNP-HSA (0.5 µg/ml) to induce cross-linking of FcεRI (XL), IL-33 (10 ng/ml) or PMA plus Ionomycin (both 1 μM) for 30 mins at 37 °C. Degranulation was determined as the % β-hexosaminidase released relative to the total activity of the cells and data are presented from a single experiment (a,b) or mean ± SEM values from the combined results of five (c) or three (d; IL-33, n = 2) independent experiments where statistical analysis was by one-way ANOVA with Bonferroni’s post test and *p < 0.05, **p < 0.01 and ***p < 0.001. WT or ST2 −/− PDMCs (e–g) and BMMCs (h,i) loaded with Fura-2/AM and sensitised or not (e) with murine anti-DNP IgE (0.5 μg/ml) were stimulated at 50 s in serum-free HBSS with 100 ng/ml IL-33. Calcium mobilisation was recorded in real-time and for the analysis of intracellular mobilisation alone, the cells were stimulated in calcium-free buffer supplemented with 100 µM EGTA to remove all extracellular calcium (−Ca2+; g, i). Data are presented as the mean (baseline subtracted) values ± SEM from replicate biological analyses collated from at least two independent experiments as follows: for PDMCs, e: IL-33, n = 3, IL-33 + IgE, n = 4; f: WT n = 6, ST2−/− n = 5; g: IL-33 n = 7, IL-33-Ca2+ n = 7; for BMMCs, h: WT n = 6, ST2−/− n = 5; i: IL-33 n = 10, IL-33-Ca2+ n = 9. Statistical analysis was by two-way ANOVA where ***p < 0.001.CC BY · PubMed Central
Figure 4 FcεRI signalling and functional responses are modulated by ST2 expression. WT or ST2−/− PDMCs (a) or BMMCs (b) sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight were cultured with DNP-HSA (0.5 μg/ml) to induce cross-linking (XL) of FcεRI for the indicated times and expression of pp44/pp42 dually phosphorylated and activated ERK1 and ERK2 relative to their total expression was analysed by Western blotting. WT or ST2−/− PDMCs (c,d) and BMMCs (e,f) sensitised with murine anti-DNP IgE (0.5 μg/ml) and loaded with Fura-2/AM were stimulated at 50 s in serum-free HBSS with DNP-HSA (0.5 μg/ml) to induce cross-linking (XL) of FcεRI. Intracellular calcium mobilisation and influx were recorded in real-time, where for the analysis of intracellular mobilisation alone (d,f), the cells were stimulated in calcium-free buffer supplemented with 100 µM EGTA to remove all extracellular calcium. Data are presented as the mean (baseline subtracted) values ± SEM from replicate biological analyses from at least two independent experiments as follows: for PDMCs, (c and d) WT n = 6, ST2−/− n = 6; for BMMCs, (e) WT n = 7, ST2−/− n = 8; (f) WT n = 9, ST2−/− n = 10. Statistical analysis was by two-way ANOVA where ***p < 0.001. PDMCs (g,i) and BMMCs (h,j) derived from WT or ST2−/− mice were sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight and stimulated with IL-33 (10 ng/ml) and/or DNP-HSA (0.5 µg/ml) for 24 h at 37 °C before release of IL-6 (g,h) and IL-13 (i,j) was measured by ELISA. Data are presented as the mean values of triplicate samples ± SD from single experiments representative of at least 2 independent experiments. Statistical analysis is by one-way ANOVA and Bonferroni’s post test where ***p < 0.001.
Figure 4 FcεRI signalling and functional responses are modulated by ST2 expression. WT or ST2−/− PDMCs (a) or BMMCs (b) sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight were cultured with DNP-HSA (0.5 μg/ml) to induce cross-linking (XL) of FcεRI for the indicated times and expression of pp44/pp42 dually phosphorylated and activated ERK1 and ERK2 relative to their total expression was analysed by Western blotting. WT or ST2−/− PDMCs (c,d) and BMMCs (e,f) sensitised with murine anti-DNP IgE (0.5 μg/ml) and loaded with Fura-2/AM were stimulated at 50 s in serum-free HBSS with DNP-HSA (0.5 μg/ml) to induce cross-linking (XL) of FcεRI. Intracellular calcium mobilisation and influx were recorded in real-time, where for the analysis of intracellular mobilisation alone (d,f), the cells were stimulated in calcium-free buffer supplemented with 100 µM EGTA to remove all extracellular calcium. Data are presented as the mean (baseline subtracted) values ± SEM from replicate biological analyses from at least two independent experiments as follows: for PDMCs, (c and d) WT n = 6, ST2−/− n = 6; for BMMCs, (e) WT n = 7, ST2−/− n = 8; (f) WT n = 9, ST2−/− n = 10. Statistical analysis was by two-way ANOVA where ***p < 0.001. PDMCs (g,i) and BMMCs (h,j) derived from WT or ST2−/− mice were sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight and stimulated with IL-33 (10 ng/ml) and/or DNP-HSA (0.5 µg/ml) for 24 h at 37 °C before release of IL-6 (g,h) and IL-13 (i,j) was measured by ELISA. Data are presented as the mean values of triplicate samples ± SD from single experiments representative of at least 2 independent experiments. Statistical analysis is by one-way ANOVA and Bonferroni’s post test where ***p < 0.001.CC BY · PubMed Central
Figure 5 PDMCs and BMMCs exhibit differential TLR4-ST2 cross-talk. PDMCs (a,b) and BMMCs (c,d) derived from WT or ST2−/− mice were sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight and then stimulated with LPS (0.5 µg/ml) and/or IL-33 (10 ng/ml) for 24 h at 37 °C before release of IL-6 (a,c) and IL-13 (b,d) was measured by ELISA. Data are presented as the mean values of triplicate samples ± SD from single experiments representative of three independent experiments. Statistical analysis is by one-way ANOVA and Bonferroni’s post test where *p < 0.05, **p < 0.001 and ***p < 0.001. Flow cytometric analysis (e–j) of WT and ST2−/− PDMCs (f,i) or BMMCs (e,g,h,j) sensitized with murine anti-DNP IgE and treated with LPS (0.5 μg/ml; WT, grey line; ST2−/−, pink line) or not (WT, black line; ST2−/−, red line) overnight. Live (7AAD−) CD117+FcεRI+ cells were analysed for ST2 (e–g) and TLR4 (h–j) expression relative to the relevant isotype controls (grey plots) in terms of the geometric mean fluorescence (GMFI). Data presented are the mean ± SEM values combined from at least three independent experiments and statistical analysis is by one-way ANOVA and Bonferroni’s post-test where **p < 0.01 and ***p < 0.001 relative to the “None” WT control.
Figure 5 PDMCs and BMMCs exhibit differential TLR4-ST2 cross-talk. PDMCs (a,b) and BMMCs (c,d) derived from WT or ST2−/− mice were sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight and then stimulated with LPS (0.5 µg/ml) and/or IL-33 (10 ng/ml) for 24 h at 37 °C before release of IL-6 (a,c) and IL-13 (b,d) was measured by ELISA. Data are presented as the mean values of triplicate samples ± SD from single experiments representative of three independent experiments. Statistical analysis is by one-way ANOVA and Bonferroni’s post test where *p < 0.05, **p < 0.001 and ***p < 0.001. Flow cytometric analysis (e–j) of WT and ST2−/− PDMCs (f,i) or BMMCs (e,g,h,j) sensitized with murine anti-DNP IgE and treated with LPS (0.5 μg/ml; WT, grey line; ST2−/−, pink line) or not (WT, black line; ST2−/−, red line) overnight. Live (7AAD−) CD117+FcεRI+ cells were analysed for ST2 (e–g) and TLR4 (h–j) expression relative to the relevant isotype controls (grey plots) in terms of the geometric mean fluorescence (GMFI). Data presented are the mean ± SEM values combined from at least three independent experiments and statistical analysis is by one-way ANOVA and Bonferroni’s post-test where **p < 0.01 and ***p < 0.001 relative to the “None” WT control.CC BY · PubMed Central
Figure 6 PDMCs and BMMCs exhibit differential ST2-dependence for calcium signalling. WT or ST2−/− PDMCs (a) or BMMCs (b) sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight were cultured with LPS (0.5 μg/ml) for the indicated times and expression of pp44/pp42 dually phosphorylated and activated ERK1 and ERK2 relative to their total expression was analysed by Western blotting. PDMCs (c,d) and BMMCs (e) sensitised with murine anti-DNP IgE (0.5 μg/ml) and loaded with Fura-2/AM were stimulated at 50 s in serum-free HBSS with LPS (0.5 μg/ml) and/or IL-33 (10 ng/ml). Calcium mobilisation data are presented as the mean (baseline subtracted) values ± SEM from replicate biological analyses as follows: for PDMCs, (c) WT n = 6, ST2−/− n = 6; (d) LPS n = 3, IL-33 n = 3, LPS + IL-33 n = 3, for BMMCs, (e) WT n = 9, ST2−/− n = 9. Statistical analysis was by two-way ANOVA where ***p < 0.001.
Figure 6 PDMCs and BMMCs exhibit differential ST2-dependence for calcium signalling. WT or ST2−/− PDMCs (a) or BMMCs (b) sensitized with murine anti-DNP IgE (0.5 μg/ml) overnight were cultured with LPS (0.5 μg/ml) for the indicated times and expression of pp44/pp42 dually phosphorylated and activated ERK1 and ERK2 relative to their total expression was analysed by Western blotting. PDMCs (c,d) and BMMCs (e) sensitised with murine anti-DNP IgE (0.5 μg/ml) and loaded with Fura-2/AM were stimulated at 50 s in serum-free HBSS with LPS (0.5 μg/ml) and/or IL-33 (10 ng/ml). Calcium mobilisation data are presented as the mean (baseline subtracted) values ± SEM from replicate biological analyses as follows: for PDMCs, (c) WT n = 6, ST2−/− n = 6; (d) LPS n = 3, IL-33 n = 3, LPS + IL-33 n = 3, for BMMCs, (e) WT n = 9, ST2−/− n = 9. Statistical analysis was by two-way ANOVA where ***p < 0.001.CC BY · PubMed Central
Figure 7 ES-62 modulates IL-33 responses. PDMCs were sensitized with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) overnight and then incubated in medium ± IL-33 (10 ng/ml) for 24 h at 37 °C before release of IL-6, IL-13 and CCL2 was measured by ELISA (a–c). Data are mean ± SD values where ***p < 0.001 and are from single experiments, which for IL-6 and IL-13 were representative of four-six experiments. Analysis of the latter data shows that ES-62 significantly reduces IL-33-induced IL-6 and IL-13 production by PDMCs to 66.03 ± 16.82 n = 5, p < 0.05 and 59.85 ± 14 n = 6, p < 0.01 of the control responses respectively and by BMMCs to 81.23 ± 5.72 n = 4, p < 0.05 and 75.75 ± 8.13 n = 5, p < 0.05 of the control responses respectively. PDMCs (d) were sensitised with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) and then loaded with Fura-2/AM and stimulated at 50 s in serum-free HBSS with IL-33 (10 ng/ml). Calcium mobilisation data are presented as the mean (baseline subtracted) values ± SEM where for IL-33, n = 3 and for IL-33 + ES-62, n = 4 replicate biological samples from a single experiment representative of at least three independent experiments. Statistical analysis was by two-way ANOVA where *** p < 0.001. WT and ST2−/− PDMCs (e,f) and BMMCs (g,h) were sensitized with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) overnight and then incubated in medium ± 0.5 µg/ml DNP-HSA plus 10 ng/ml IL-33 (XL + IL-33) for 24 h at 37 °C before release of IL-6 (e,g) and IL-13 (f,h) was measured by ELISA. Data are mean ± SD values where ***p < 0.001. Analysis of 3 independent experiments showed that ES-62 reduced IL-33 + XL-stimulated IL-6 and IL-13 production by PDMCs to 79.27 ± 12.42 and 59.98 ± 10.07, p < 0.05 of the control responses respectively and by BMMCs to 65.11 ± 26.72 and 65.60 ± 20.43, p < 0.05 of the control responses in WT, but not ST2KO mast cells.
Figure 7 ES-62 modulates IL-33 responses. PDMCs were sensitized with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) overnight and then incubated in medium ± IL-33 (10 ng/ml) for 24 h at 37 °C before release of IL-6, IL-13 and CCL2 was measured by ELISA (a–c). Data are mean ± SD values where ***p < 0.001 and are from single experiments, which for IL-6 and IL-13 were representative of four-six experiments. Analysis of the latter data shows that ES-62 significantly reduces IL-33-induced IL-6 and IL-13 production by PDMCs to 66.03 ± 16.82 n = 5, p < 0.05 and 59.85 ± 14 n = 6, p < 0.01 of the control responses respectively and by BMMCs to 81.23 ± 5.72 n = 4, p < 0.05 and 75.75 ± 8.13 n = 5, p < 0.05 of the control responses respectively. PDMCs (d) were sensitised with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) and then loaded with Fura-2/AM and stimulated at 50 s in serum-free HBSS with IL-33 (10 ng/ml). Calcium mobilisation data are presented as the mean (baseline subtracted) values ± SEM where for IL-33, n = 3 and for IL-33 + ES-62, n = 4 replicate biological samples from a single experiment representative of at least three independent experiments. Statistical analysis was by two-way ANOVA where *** p < 0.001. WT and ST2−/− PDMCs (e,f) and BMMCs (g,h) were sensitized with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) overnight and then incubated in medium ± 0.5 µg/ml DNP-HSA plus 10 ng/ml IL-33 (XL + IL-33) for 24 h at 37 °C before release of IL-6 (e,g) and IL-13 (f,h) was measured by ELISA. Data are mean ± SD values where ***p < 0.001. Analysis of 3 independent experiments showed that ES-62 reduced IL-33 + XL-stimulated IL-6 and IL-13 production by PDMCs to 79.27 ± 12.42 and 59.98 ± 10.07, p < 0.05 of the control responses respectively and by BMMCs to 65.11 ± 26.72 and 65.60 ± 20.43, p < 0.05 of the control responses in WT, but not ST2KO mast cells.CC BY · PubMed Central
Figure 8 ST2 deficiency impacts differentially on ES-62-mediated modulation of signalling in PDMCs and BMMCs. WT and ST2−/− PDMCs (a,b) and BMMCs (c,d) were sensitized with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) overnight and then incubated in medium ± IL-33 (10 ng/ml) and/or LPS (0.5 µg/ml) for 24 h at 37 °C before release of IL-6 (a,c) and IL-13 (b,d) was measured by ELISA. Data are mean ± SD values from a single experiment representative of at least two independent experiments where ***p < 0.001. Statistical analysis where three independent experiments were performed showed that whilst treatment with ES-62 resulted in 39.5 ± 19.8% p < 0.05 of the LPS- and 78.8 ± 9.0% p < 0.05 of IL33 + LPS-stimulated IL-13 production by WT PDMCs relative to the appropriate control responses, this inhibition was abolished (106 ± 10 and 106 ± 6% of the LPS and IL-33 + LPS control responses, respectively) in ST2KO PDMCs. By contrast, the LPS-induced release of IL-13 was inhibited by ES-62 in both WT and ST2−/− BMMCs (70.6 ± 6.7% WT and 63.5 ± 9.2% p < 0.05 control responses, respectively).
Figure 8 ST2 deficiency impacts differentially on ES-62-mediated modulation of signalling in PDMCs and BMMCs. WT and ST2−/− PDMCs (a,b) and BMMCs (c,d) were sensitized with murine anti-DNP IgE (0.5 μg/ml) in the presence or absence of ES-62 (2 µg/ml) overnight and then incubated in medium ± IL-33 (10 ng/ml) and/or LPS (0.5 µg/ml) for 24 h at 37 °C before release of IL-6 (a,c) and IL-13 (b,d) was measured by ELISA. Data are mean ± SD values from a single experiment representative of at least two independent experiments where ***p < 0.001. Statistical analysis where three independent experiments were performed showed that whilst treatment with ES-62 resulted in 39.5 ± 19.8% p < 0.05 of the LPS- and 78.8 ± 9.0% p < 0.05 of IL33 + LPS-stimulated IL-13 production by WT PDMCs relative to the appropriate control responses, this inhibition was abolished (106 ± 10 and 106 ± 6% of the LPS and IL-33 + LPS control responses, respectively) in ST2KO PDMCs. By contrast, the LPS-induced release of IL-13 was inhibited by ES-62 in both WT and ST2−/− BMMCs (70.6 ± 6.7% WT and 63.5 ± 9.2% p < 0.05 control responses, respectively).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 1

  1. Rzepecka, J. et al. The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype. International Journal for Parasitology, https://doi.org/10.1016/j.ijpara.2012.12.001. · DOI · Paper page

Cited by

See all 198

Metadata

Authors
Ball, D. H., Al-Riyami, L., Harnett, W., & Harnett, M. M.
Affiliations
  • University of Glasgow (GB)
  • University of Strathclyde (GB)
Corresponding author
Harnett, Margaret M.
Venue
Scientific Reports
Published
2018-03-14
Volume
8
Issue
1
Pages
4497-4497
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2793153047
Cited by
197
References
59
Citations by year
2026: 3 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 104 · 2020: 59 · 2019: 11 · 2018: 9
FWCI
19.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Wellcome Trust (086852)
  • Medical Research Council
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
ES-62, FcεRI, TLR4, MyD88, mast cells, asthma, serosal mast cells, mucosal mast cells, receptor cross-talk, allergy treatment
MeSH terms
Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Animals, Mast Cells, Protein Binding, Signal Transduction, Cell Degranulation, Helminth Proteins, Cytokines, Receptors, IgE, Mice, Knockout, Inflammation Mediators, Toll-Like Receptor 4, Mice, Immunomodulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62. https://app.cochat.ai/papers/10.1038/s41598-018-22716-9
The paper
Ball, D. H., Al-Riyami, L., Harnett, W., & Harnett, M. M. (2018). IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62. Scientific Reports. https://doi.org/10.1038/s41598-018-22716-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.